Ultime notizie per Lifeway Foods (NASDAQ:LWAY) Azioni

Lifeway Foods

Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through direct sales force, brokers, and distributors.

WallStreet.Banks.Shutterstock

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

AGRO

DOLE

LWAY

Un&#39;analisi sui titoli che potrebbero presentare rischi nel breve termine. Gli indicatori chiave e le valutazioni degli esperti.

3 titoli che potrebbero deludere gli investitori questo mese

Lifeway Foods Inc

Lifeway Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.19 by 21.05 percent. This is a 43.75 percent increase over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $46.09 million which missed the analyst consensus estimate of $48.50 million by 4.97 percent. This is a 3.26 percent increase over sales of $44.63 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Lifeway Foods Q1 EPS $0.23 Beats $0.19 Estimate, Sales $46.09M Miss $48.50M Estimate

Edward Smolyansky, who together with Ludmila Smolyansky, beneficially own approximately 27% of outstanding shares of Lifeway Foods common stock, today issued the following statement in response to Lifeway's amended 2024 Annual Report and its latest disclosures on executive and director compensation.
Apparent Delay of 2025 Annual Meeting of Shareholders
On March 13, Edward Smolyansky submitted a full slate of Board nominees for Lifeway's 2025 Annual Meeting. To date, Lifeway has yet to file a preliminary or definitive proxy statement setting forth its own slate.
"The filing of the amended 2024 Annual Report, and other steps taken recently by the Company, suggest to me that the Board is planning to delay the 2025 Annual Meeting of Shareholders past the June 2, 2025, date provided for in the bylaws," said Mr. Smolyansky. "I am prepared to make my case to our fellow shareholders - at the annual meeting or otherwise - and it is disappointing that the Board is not prepared to do the same."
Any attempt to delay the annual meeting or sidestep the proxy contest would reflect yet another act of hostility toward shareholders, led by CEO/Chair Julie Smolyansky and endorsed by an entrenched and ineffective Board.
The Company is clearly at an inflection point as shareholders rightly question whether the Board's rejection of Danone's offer –&nbsp;at a significant premium to the then-current share price – served the interests of directors and executives over those of shareholders, especially given the hostile actions toward Danone and the exorbitant compensation awarded to Julie Smolyansky in the immediate aftermath.
In December 2024, the Board awarded Ms. Smolyansky a $2 million retention bonus and a $6.5 million equity grant1&nbsp;without providing any rationale in Lifeway's updated compensation disclosures. It also quietly increased her change-in-control severance multiple from 2x to 3x her base salary. These rewards came in a year when Lifeway's earnings declined by 20.6%.
Legal and Regulatory Dysfunction
Under Ms. Smolyansky's leadership, Lifeway has initiated multiple lawsuits against its largest shareholders, including Edward and Ludmila Smolyansky. These legal actions raise questions about governance, internal controls, and the misuse of shareholder funds. They also potentially undermine Lifeway's standing and influence in future court proceedings.
The company has been embroiled in multiple legal disputes, including a federal trade infringement lawsuit against former executives Edward and Ludmila Smolyansky along with their new venture, Pure Culture Organics&#x2122; that was dismissed with prejudice, permanently barring Lifeway from bringing the same claim again. Perhaps more troubling, Burdeen's multiple false declarations in the case have eroded Lifeway's credibility in court, while his broader involvement has significantly weakened the company's legal and strategic standing.
"Julie would rather spend her time –&nbsp;and shareholders' dollars –&nbsp;suing her own family than leading Lifeway through today's volatile economy," said Edward Smolyansky. "Every lawsuit filed against me has either been dismissed, dropped, or defeated. The Board should not be enabling such meritless, retaliatory legal actions."
To date, Lifeway has spent over $1 million pursuing legal claims against Edward Smolyansky, with no return for shareholders – an expense that calls into question the Board's legal oversight and risk management processes.
No Legal Department –&nbsp;But a "Chief of Staff" Acting as One
In January 2020, Lifeway eliminated its entire internal legal department, including the senior position of General Counsel. Since then, the company has relied exclusively on outside counsel for its aggressive legal efforts –&nbsp;again, at great cost to shareholders.
With no legal team in place, Jason Burdeen, CEO Julie Smolyansky's husband and Chief of Staff, has assumed wide-ranging control over legal matters. Burdeen holds no law degree, no legal training, and no relevant background in compliance or corporate governance. Despite this, he has exercised influence over nearly every aspect of Lifeway's operations, including its legal strategy, personnel decisions, and internal oversight.
According to Lifeway's 10-K/A filed April 29, despite not holding a formal employment agreement, Burdeen received a total compensation package of $313,800 in 2024 – 30% more than the year before. This included a $100,000 "short-term incentive cash bonus." Lifeway has neglected to explain what warranted that bonus.
"Shareholders deserve to know whether that bonus was awarded for performance, or for consolidating control and absorbing responsibilities once held by Lifeway's former General Counsel and Senior EVP of Sales," said Edward Smolyansky.
Ironically, Lifeway's own governance policy instructs employees to report concerns to the General Counsel or legal department, neither of which currently exists.
Warranted Change is Imminent
While the Board continues to stall and evade accountability, Edward and Ludmila Smolyansky are determined to continue pressing Lifeway to immediately set a date for the 2025 Annual Meeting and proceed with director elections as required.

Edward Smolyansky, Together With Ludmila Smolyansky, Who Beneficially Own ~27% Of Outstanding Shares Of Lifeway Foods Common Stock, Issues Statement In Response To Lifeway's Amended 2024 Annual Report

Insider Trades

Reported May, 1 2025: Lifeway Foods Form4 Filing Shows Ludmila Smolyansky Sold 20,518 Shares At An Average Price Of $23.77/Share

Reported Earlier, Lifeway Foods Hits Record $5M Weekly Gross Sales, Up 35% YoY On Surging Demand For Kefir And Farmer Cheese

As of April 3, 2025, three stocks in the consumer staples sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Dole PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOLE#NYSE">DOLE</a>)</h3>
<ul>
<li>On Feb. 26, Dole posted better-than-expected fourth-quarter financial results. The company's stock gained around 5% over the past five days and has a 52-week high of $17.12.</li>
<li>RSI Value: 71.2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>DOLE Price Action: Shares of Dole gained 1.1% to close at $14.66 on Wednesday.</li>
<li>Edge Stock Ratings: 75.90 Momentum score with Value at 85.83. </li>
</ul>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/dole"><img loading="lazy" decoding="async" width="441" height="177" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03043731/image-1-7.png" alt="" class="wp-image-854816" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03043731/image-1-7.png 441w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/03043731/image-1-7-300x120.png 300w" sizes="(max-width: 441px) 100vw, 441px" /></a></figure>
<h3 class="wp-block-heading">Adecoagro SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGRO#NYSE">AGRO</a>)</h3>
<ul>
<li>On March 27, Adecoagro announced a deal with Tether Investments, under which Tether will launch a tender offer to acquire a majority stake in the South American agribusiness at $12.41 per share. Adecoagro CEO and Co-Founder Mariano Bosch said, "I am very excited about this transaction and the opportunity to have a significant shareholder like Tether, who shares the entrepreneurial spirit that led us to create Adecoagro 23 years ago and that continues to be present in our day-to-day decisions." The company's stock gained around 5% over the past month and <a href="https://www.benzinga.com/quote/AGRO">has a 52-week high</a> of $12.08.</li>
<li>RSI Value: 73.5</li>
<li>AGRO Price Action: Shares of Adecoagro gained 0.1% to close at $11.36 on Wednesday.</li>
</ul>
<h3 class="wp-block-heading">Lifeway Foods Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>)</h3>
<ul>
<li>On March 14, Lifeway Foods posted weaker-than-expected quarterly results. &#8220;I am pleased to report another record year of net sales for Lifeway, spearheaded by the continued, strong volume growth of our flagship drinkable Lifeway Kefir,&#8221; commented Julie Smolyansky, President and Chief Executive Officer of Lifeway. The company's stock gained around 19% over the past month and has a <a href="https://www.benzinga.com/quote/LWAY">52-week high</a> of $28.61.</li>
<li>RSI Value: 74.6</li>
<li>LWAY Price Action: Shares of Lifeway Foods gained 0.6% to close at $24.84 on Wednesday.</li>
</ul>
Learn more about BZ Edge Rankings—click to see scores for other <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">stocks in the sector and see how they compare.</a> 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44604078/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-with-over-6-dividend-yields">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks With Over 6% Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

Top 3 Risk Off Stocks That Are Ticking Portfolio Bombs

Lifeway notes that Edward Smolyansky was previously terminated for cause as an officer of the company.
Lifeway said Audit and Corporate Governance Committee will review Mr. Smolyansky's nominees, and the Board will make a recommendation in due course. &nbsp;

Lifeway Foods Issues Response Regarding Edward Smolyansky's Nomination Notice With Respect To Seven Candidates To Board; Asks Shareholders Not To Take Any Action At This Time

Lifeway Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) reported quarterly losses of $(0.01) per share which missed the analyst consensus estimate of $0.21 by 104.76 percent. This is a 103.85 percent decrease over earnings of $0.26 per share from the same period last year. The company reported quarterly sales of $46.93 million which missed the analyst consensus estimate of $48.00 million by 2.22 percent. This is a 11.50 percent increase over sales of $42.09 million the same period last year.

Lifeway Foods Q4 EPS $(0.01) Misses $0.21 Estimate, Sales $46.93M Miss $48.00M Estimate

Reported Earlier, Lifeway Farmer Cheese Grows Retail Presence With Rollout To 1,400 Albertsons Locations

Lifeway was an early investor in Simple Foods in 2015 and since that time, the Company has already realized a $1.5 million gain in 2019, bringing the total expected net proceeds to Lifeway of approximately $6.5 million.

Lifeway Foods Expects To Realize Approximately $5M Of Net Profit Due To Recently Announced Sale Of Simple Foods To Flowers Foods

Edward Smolyansky said, "Lifeway seems determined to plunge the Company deeper and deeper into litigation this time via proxy by Julie. We look forward to providing all shareholders a fully transparent accounting of the inner workings of America's Worst Governed Publicly Traded Company."
Ludmila Smolyansky stated, "After they cut a check to Julie for $2 million, I anticipated that she would file a lawsuit against Edward the following month." Mrs. Smolyansky continued, "On January 23, Julie filed suit. In anticipation of this, on January 3, I began to sell some of my shares to defend Edward. I have no choice, as&nbsp;Lifeway's legal counsel has refused to provide the adequate paperwork to Edward to monetize his holdings in LWAY as permitted under our 1999 Shareholders Agreement between our family member and Group Danone

Reported Earlier, Edward And Ludmila Smolyansky Demand Lifeway Foods CEO Ends Legal Battle

<ul>
<li>Company also announces unaudited preliminary fourth quarter net sales between $45.1 million to $46.6 million</li>
<li>Full year 2024 preliminary unaudited net sales are projected to range between $185.0 million and $186.5 million compared to $160.1 million in 2023</li>
</ul>
MORTON GROVE, Ill., Jan. 6, 2025 /PRNewswire/ --&nbsp;Lifeway Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) ("Lifeway" or the "Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced that its Board of Directors (the "Board") has responded to the December 30, 2024 letter sent to Lifeway by Danone North America PBC ("Danone") reaffirming that the Company rejected Danone's offer to acquire the Company because it severely undervalues the Company, based on analysis by the Company's independent financial and legal advisors. The Board reiterated that it is not opposed to a sale at a price that more accurately reflects the true value of the Company.

Guidance

Lifeway Foods Responds To Letter From Danone North America PBC Reaffirming Rejection Of Unsolicited Takeover Offer; Also Announces Unaudited Preliminary Q4 Net Sales Between $45.1M-$46.6M; FY24 Preliminary Unaudited Net Sales Are Projected To Range Between $185M-$186.5M Compared To $160.1M In 2023

ifeway Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) (the "Company" or "Lifeway"), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today provided additional information regarding the reasons that its Board of Directors rejected the revised unsolicited proposal made on November 15, 2024 by Danone North America PBC ("Danone") to acquire all the shares of Lifeway that it does not already own for $27.00 per share.
The Board determined that Danone's $27.00 per share proposal substantially undervalues the Company. The Board is not, however, opposed to the sale of the Company at any price.
The Board has carefully evaluated the Company's standalone plan&nbsp;and believes it has strong potential to provide superior value to all shareholders as compared to Danone's revised proposal. The Board takes its fiduciary duties seriously and is committed to acting in the best interests of all of the Company's shareholders and other stakeholders.

DANOY

Lifeway Foods Rejects Danone's $27 Per Share Acquisition Proposal, Citing Undervaluation Of The Company

Edward And Ludmila Smolyansky Urge Lifeway Foods To Form Special Committee To Evaluate Danone's $27 Per Share Cash Offer Amid Board's Rejection And Legal Disputes

Lifeway Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) shares are trading lower on Wednesday after the company&#8217;s Board of Directors rejected a revised unsolicited <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n42085549/lifeway-foods-rejects-revised-unsolicited-proposal-from-danone" rel="noreferrer noopener">acquisition proposal from </a><a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n42085549/lifeway-foods-rejects-revised-unsolicited-proposal-from-danone" rel="noreferrer noopener">Danone North America PBC</a>.
The proposal on November 15 offered $27.00 per share to acquire all of Lifeway&#8217;s shares that Danone does not already own.
After careful evaluation, including consultations with independent financial and legal advisors, the Lifeway Board determined that the offer significantly undervalued the company and was not in the best interests of Lifeway&#8217;s shareholders or other stakeholders.
According to a recent Schedule 13D amendment filing, Danone beneficially owns approximately&nbsp;23.3%&nbsp;of <a target="_blank" href="https://www.benzinga.com//node/42019636" rel="noreferrer noopener">Lifeway&#8217;s outstanding common stock.</a>
On&nbsp;November 5, 2024, Lifeway announced that its Board had rejected Danone&#8217;s initial unsolicited, non-binding proposal of&nbsp;$25.00&nbsp;per share, citing that it <a target="_blank" href="https://www.benzinga.com//node/41745068" rel="noreferrer noopener">substantially undervalued the company.</a>
Lifeway said it remains committed to its strategic plan of expanding its kefir offerings while also branching into adjacent product categories.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/11/42085436/target-q3-earnings-supply-chain-chaos-hits-bottomline-slashes-annual-profit-outlook-stock-tanks" rel="noreferrer noopener">Target Q3 Earnings: Supply Chain Chaos Hits Bottomline, Slashes Annual Profit Outlook, Stock Tanks</a>
The company reported growth in its third-quarter 2024 results, achieving its 20th consecutive quarter of growth with double-digit year-over-year revenue growth and improved profit margins.
Lifeway said it generated a total shareholder return of 788% over the past five years, vastly outperforming its food and beverage industry peers and the S&amp;P 500.
In line with its growth momentum, Lifeway has also announced the launch of a new functional beverage: Probiotic Smoothie + Collagen <a target="_blank" href="https://www.benzinga.com/pressreleases/24/11/n42089631/lifeway-foods-announces-latest-innovation-probiotic-smoothie-collagen" rel="noreferrer noopener">made with kefir cultures. </a>This product comes in four flavors—Matcha Latte, Berry Blast, Tropical Fruit, and Plain—and contains 5 grams of collagen per serving. It is also lactose-free, capitalizing on the growing consumer demand for lactose-free dairy alternatives.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, LWAY stock has gained over 56% in the past year.
Price Action: LWAY shares are trading lower by 5.72% to $23.89 at last check Wednesday.
Photo via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/health-care/24/11/42087908/mutated-bird-flu-case-in-california-puts-humans-at-increased-risk-so-which-companies-are-developing-vaccines" target="_blank" rel="noreferrer noopener">Mutated Bird Flu Case In California Puts Humans At Increased Risk, So Which Companies Are Developing Vaccines?</a></li>
</ul>

Equities

Movers

General

What's Going On With Lifeway Stock After Rejecting Revised Acquisition Offer From Danone?

Lifeway Foods Announced That Its Board Of Directors Has Rejected The Revised Unsolicited Proposal Made On November 15, 2024 By Danone North America To Acquire All The Shares Of Lifeway That It Does Not Already Own For $27.00 Per Share

Lifeway Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) ("Lifeway" or the "Company"), a leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, confirmed that it has received a revised, unsolicited, non-binding proposal from Danone North America PBC ("Danone") to acquire all outstanding shares of common stock of Lifeway it does not already own for $27.00 per share in cash. According to the Schedule 13D amendment filed today with the U.S. Securities and Exchange Commission disclosing the revised proposal, Danone beneficially owns approximately 23.3% of Lifeway's outstanding common stock.
On November 5, 2024, Lifeway announced that its Board of Directors (the "Board") had rejected Danone's initial unsolicited, non-binding proposal to acquire all the shares of Lifeway that it does not already own for $25.00 per share because the Board determined that the initial proposal substantially undervalued Lifeway and was not in the best interests of the Company and its shareholders and other stakeholders.
Consistent with its fiduciary duties, Lifeway's board of directors, in consultation with its independent outside advisors, will carefully review and evaluate the revised proposal to determine the course of action that it believes is in the best interests of the Company and its shareholders and other stakeholders.
The Company does not undertake any obligation to provide any updates with respect to this or any other proposal or transaction, except as required under applicable law.
Lifeway shareholders do not need to take any action at this time.
Evercore is serving as a financial advisor to Lifeway and Sidley Austin LLP is serving as legal counsel to Lifeway.

Lifeway Foods Confirms Receipt Of Revised, Unsolicited, Non-Binding Proposal From Danone  To Acquire All Outstanding Shares Of Common Stock Of Lifeway It Does Not Already Own For $27.00 Per Share In Cash

U.S. stocks were lower, with the Dow Jones index falling around 300 points on Friday.
Shares of Despegar.com, Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DESP#NYSE">DESP</a>) rose sharply during Friday's session after the company reported <a href="https://www.benzinga.com/quote/DESP/earnings">better-than-expected third-quarter sales.</a>
The company said it sees FY24 revenue of at least $760 million and adjusted EBITDA of at least $170 million
Despegar.com shares jumped 19.1% to $17.70 on Friday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Bloom Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) shares jumped 43% to $18.98. Bloom Energy announced a 1 GW fuel cell deal with AEP, providing clean power for AI Data Centers.</li>
<li>Red Cat Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) gained 22.3% to $4.9200.</li>
<li>Intuitive Machines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUNR#NASDAQ">LUNR</a>) gained 13% to $11.56. The company reported third-quarter results on Thursday.</li>
<li>Century Aluminum Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CENX#NASDAQ">CENX</a>) rose 12.6% to $23.77.</li>
<li>COMPASS Pathways plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CMPS#NASDAQ">CMPS</a>) jumped 12.5% to $5.50.</li>
<li>Lifeway Foods, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) gained 11% to $24.85. The company reported quarterly results on Thursday.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) rose 10.3% to $5.13. Kingsoft Cloud Holdings will release its unaudited financial results for the third quarter before the open of U.S. markets on Tuesday, Nov. 19.</li>
<li>Alcoa Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AA#NYSE">AA</a>) gained 7.7% to $44.40.</li>
<li>Zai Lab Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZLAB#NASDAQ">ZLAB</a>) shares rose 6.3% to $28.34. The company priced a $200 million public offering of 7,843,137 shares at $25.50 per ADS.</li>
<li>Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) gained 6% to $62.72 after the company announced it will transfer its stock exchange listing over to the Nasdaq.</li>
<li>The Walt Disney Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) rose 3% to $112.38. The company reported quarterly results on Thursday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/11/42007586/top-4-energy-stocks-that-could-blast-off-in-november">Top 4 Energy Stocks That Could Blast Off In November</a></li>
</ul>

CENX

CMPS

DESP

LUNR

PLTR

RCAT

ZLAB

Despegar.com, Zai Lab, Bloom Energy And Other Big Stocks Moving Higher On Friday

<a href="https://www.sec.gov/Archives/edgar/data/814586/000119312524259418/d880074dsc13da.htm" title="https://www.sec.gov/Archives/edgar/data/814586/000119312524259418/d880074dsc13da.htm">https://www.sec.gov/Archives/edgar/data/814586/000119312524259418/d880074dsc13da.htm</a>

Danone North America PBC Sent Second Letter To Lifeway Foods To Express Disappointment In Board's Response To Initial Proposal; Reiterates Danone North America PBC's Strong Commitment To Proposed Transaction; Updated Proposal, Danone North America PBC Increased Offer For Proposed Transaction From $25.00/Share To $27.00/Share

Lifeway Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) reported quarterly earnings of $0.19 per share which missed the analyst consensus estimate of $0.27 by 29.63 percent. The company reported quarterly sales of $46.095 million which missed the analyst consensus estimate of $49.750 million by 7.35 percent. This is a 12.71 percent increase over sales of $40.896 million the same period last year.

Lifeway Foods Q3 2024 GAAP EPS $0.19 Misses $0.27 Estimate, Sales $46.095M Miss $49.750M Estimate

Lifeway Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LWAY#NASDAQ">LWAY</a>) will release its quarterly earnings report on Thursday, 2024-11-14. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Lifeway Foods to report an earnings per share (EPS) of $0.27.
The announcement from Lifeway Foods is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Earnings Track Record</h3>
During the last quarter, the company reported an EPS beat by $0.05, leading to a 6.84% increase in the share price on the subsequent day.
Here's a look at Lifeway Foods's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.20</td>
<td>0.24</td>
<td>0.21</td>
<td>0.16</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.25</td>
<td>0.16</td>
<td>0.26</td>
<td>0.23</td>
</tr>
<tr>
<td>Price Change %</td>
<td>7.000000000000001%</td>
<td>-6.0%</td>
<td>9.0%</td>
<td>39.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1731521045_0.png" alt="eps graph" />
<h3>Tracking Lifeway Foods's Stock Performance</h3>
Shares of Lifeway Foods were trading at $24.15 as of November 12. Over the last 52-week period, shares are up 57.14%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<h3>Analyst Views on Lifeway Foods</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on Lifeway Foods.
Lifeway Foods has received a total of 1 ratings from analysts, with the consensus rating as Outperform. With an average one-year price target of $25.0, the consensus suggests a potential 3.52% upside.
<h3>Peer Ratings Overview</h3>
This comparison focuses on the analyst ratings and average 1-year price targets of and Mama`s Creations, three major players in the industry, shedding light on their relative performance expectations and market positioning.
<ul>
<li>For Mama`s Creations, analysts project an Buy trajectory, with an average 1-year price target of $10.0, indicating a potential 58.59% downside.</li>
</ul>
<h3>Peer Metrics Summary</h3>
The peer analysis summary offers a detailed examination of key metrics for and Mama`s Creations, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Lifeway Foods</td>
<td>Outperform</td>
<td>25.30%</td>
<td>$13.28M</td>
<td>5.75%</td>
</tr>
<tr>
<td>Mama`s Creations</td>
<td>Buy</td>
<td>14.49%</td>
<td>$6.88M</td>
<td>5.38%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Lifeway Foods ranks higher than its peers in terms of revenue growth and gross profit. However, it has a lower return on equity compared to its peers. Overall, Lifeway Foods is positioned favorably among its peers based on the provided metrics.
<h3>About Lifeway Foods</h3>
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir which is a cultured dairy product. Its product categories are Drinkable Kefir which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir and Other dairy. The company manufacture and market products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products primarily through direct sales force, brokers, and distributors.
<h3>Key Indicators: Lifeway Foods's Financial Health</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Lifeway Foods's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 25.3% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Lifeway Foods's net margin is impressive, surpassing industry averages. With a net margin of 7.7%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Lifeway Foods's ROE stands out, surpassing industry averages. With an impressive ROE of 5.75%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Lifeway Foods's ROA stands out, surpassing industry averages. With an impressive ROA of 4.51%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.0, Lifeway Foods adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/LWAY/earnings">To track all earnings releases for Lifeway Foods visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Exploring Lifeway Foods's Earnings Expectations

Press Releases

Lifeway Foods® to Showcase New Probiotic Salad Dressing Innovations and Conventional Whole Milk Kefir Expansion at Natural Products Expo West 2025

Lifeway Foods® CEO Julie Smolyansky to Appear with Katie Couric at the SHE Media Co-Lab at SXSW® to Discuss Gut Health Trends and History of Lifeway Kefir

LIFEWAY FOODS STATEMENT REGARDING DANONE'S LATEST ACTIONS, CONTINUING DANONE'S HISTORY AS A TOXIC BUSINESS PARTNER

Lifeway Foods® Announces Strong Fourth Quarter and Record-Breaking Full Year 2024 Results

Edward Smolyansky Launches Campaign to Replace Board of Directors at Lifeway Foods (NASDAQ: LWAY)

After Reporting Record Full Year 2024 Earnings and 22nd Consecutive Quarter of Growth, Lifeway Foods Issues Statement on Edward Smolyansky's Director Nomination Notice

Comments

Lifeway Foods

Notizie

Ultime notizie per Lifeway Foods (NASDAQ:LWAY) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO